title: Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
abstract: The viaB locus coding for the Vi antigen of Salmonella typhi Ty2 was cloned on a 40.6-kilobase fragment into the cosmid vector pHC79. The live, oral, attenuated Vi-negative S. typhi Ty21a vaccine strain was transformed with the recombinant cosmid encoding the viaB locus. Homologous recombination of the viaB locus into the chromosome of S. typhi Ty21a was induced by UV irradiation, and Vi-positive recombinants were selected in the presence of D-cycloserine. One such isolate, termed WR4103, contained no plasmids or the attendant antibiotic resistance markers and expressed the Vi antigen stably. Vi antigen extracted from WR4103 was immunologically indistinguishable from Vi antigen purified from S. typhi Ty2. The only detectable difference between Ty21a and WR4103 was in the production of Vi antigen. The mean lethal doses of Ty21a and WR4103 for mice were nearly identical. Immunization of mice with WR4103 engendered a Vi antibody response and afforded complete protection against fatal infection with virulent S. typhi Ty2. Thus, S. typhi WR4103 may serve as an improved oral vaccine for protection against typhoid fever.
authors: Swiss Serum and Vaccine Institute, Bern.
authors: S J
authors: SJ
authors: Cryz
authors: E
authors: E
authors: Fürer
authors: L S
authors: LS
authors: Baron
authors: K F
authors: KF
authors: Noon
authors: F A
authors: FA
authors: Rubin
authors: D J
authors: DJ
authors: Kopecko
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology*; D001426:Bacterial Proteins / Q000032:analysis; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology*; D003001:Cloning, Molecular; D005690:Galactose / Q000378:metabolism; D008099:Liver / Q000382:microbiology; D051379:Mice; D010641:Phenotype; D011135:Polysaccharides, Bacterial; D012485:Salmonella typhi / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D013154:Spleen / Q000382:microbiology; D014435:Typhoid Fever / Q000382:microbiology / Q000517:prevention & control; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial; D014612:Vaccines; D014614:Vaccines, Synthetic; D005690:Galactose